Competitive inhibition of cell binding induced by B5V60 towards anti-STn antibody could be useful in STn-based targeting of cancer cells as a drug delivery system as well as in enhancing immune responses against immunotolerant tumor cells highly expressing STn. The gene discussed is EEF1A2; the disease is cancer.